Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
14,852
+149
+1% +$17.4K 0.43% 57
2026
Q1
$1.77M Buy
14,703
+4
+0% +$462 0.5% 53
2025
Q4
$1.55M Sell
14,699
-497
-3% -$46.7K 0.43% 62
2025
Q3
$1.28M Sell
15,196
-115
-0.8% -$9.47K 0.36% 75
2025
Q2
$1.25M Sell
15,311
-526
-3% -$41.8K 0.38% 72
2025
Q1
$1.42M Sell
15,837
-1,460
-8% -$136K 0.49% 58
2024
Q4
$1.72M Buy
17,297
+1,129
+7% +$116K 0.6% 49
2024
Q3
$1.84M Buy
16,168
+262
+2% +$31.1K 0.67% 42
2024
Q2
$1.97M Buy
15,906
+45
+0.3% +$5.8K 0.76% 34
2024
Q1
$2.09M Buy
+15,861
New +$1.95M 0.86% 34

Other funds holding MRK

Umpqua Bank's MRK Position: Q2 2026 in Review

Umpqua Bank increased its Merck (MRK) stake by 1% in Q2 2026, buying an estimated $17.4K and bringing the position to 14,852 shares worth $1.91M. The position accounts for 0.43% of the portfolio, ranked #57.

Umpqua Bank first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.09M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Umpqua Bank held 14,852 shares of Merck worth $1.91M as of Q2 2026.
  • Umpqua Bank bought 149 Merck shares in Q2 2026, an estimated $17.4K.
  • Merck made up 0.43% of Umpqua Bank's portfolio in Q2 2026, its #57 holding.
  • Umpqua Bank first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Umpqua Bank's Merck position peaked at $2.09M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Umpqua Bank's 13F filing for Q2 2026, filed 24 Jul 2026.